Statistics

Total Visits

Views
NeoHx study: Perioperative treatment with trastuzumab in combination with capecitabine and oxaliplatin (XELOX-T) in patients with HER2 resectable stomach or esophagogastric junction (EGJ) adenocarcinoma-R0 resection, pCR, and toxicity analysis42

Select a period of time:

Number of views in the range

Views
NeoHx study: Perioperative treatment with trastuzumab in combination with capecitabine and oxaliplatin (XELOX-T) in patients with HER2 resectable stomach or esophagogastric junction (EGJ) adenocarcinoma-R0 resection, pCR, and toxicity analysis28

Views

Views
January 20250
February 20251
March 202514
April 20252
May 20255
June 20256
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore25
United States2
Spain1
 

Top cities views

Views
Council Bluffs1